An overview of "the guideline for clinical research using human stem cells"

Akifumi Matsuyama

研究成果: Article査読

3 被引用数 (Scopus)

抄録

A medical system is anticipated, where high-quality medical services are accessible without anxieties whenever we are ill or injured. The innovative regenerative medical products have enabled us to overcome some life threatening diseases, however, challenges still remain for others. The Ministry of Health, Labour and Welfare has implemented "The guideline for clinical research using human stem cells" and has launched on Sept 1, 2006. The major goal of the guideline is to reinforce and ensure safe on investigational new regenerative medical products. In this paper, I will give an overview of the guideline for clinical research using human stem cells, which intends to satisfy unmet medical needs in the field of regenerative medicine as well as to keep medical advances in Japan.

本文言語English
ページ(範囲)843-849
ページ数7
ジャーナルNippon rinsho. Japanese journal of clinical medicine
66
5
出版ステータスPublished - 05-2008
外部発表はい

All Science Journal Classification (ASJC) codes

  • Medicine(all)

フィンガープリント 「An overview of "the guideline for clinical research using human stem cells"」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル